Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Does defibrotide prophylaxis decrease the risk of acute graft versus host disease following allogeneic hematopoietic cell transplantation?
Tekgündüz E, Kaya AH, Bozdağ SC, Koçubaba Ş, Kayıkçı Ö, Namdaroğlu S, Uğur B, Akpınar S, Batgi H, Bekdemir F, Altuntaş F. Tekgündüz E, et al. Among authors: akpinar s. Transfus Apher Sci. 2016 Feb;54(1):30-4. doi: 10.1016/j.transci.2016.01.009. Epub 2016 Jan 12. Transfus Apher Sci. 2016. PMID: 26922995
Sticky platelet syndrome in patients with uninduced venous thrombosis.
Tekgündüz E, Demir M, Akyol Erikçi A, Akpınar S, Oztürk E, Kırkızlar O. Tekgündüz E, et al. Among authors: akpinar s. Turk J Haematol. 2013 Mar;30(1):48-52. doi: 10.5152/tjh.2011.79. Epub 2013 Mar 5. Turk J Haematol. 2013. PMID: 24385753 Free PMC article.
A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study.
Tekgündüz E, Yılmaz M, Erkurt MA, Kiki I, Kaya AH, Kaynar L, Alacacioglu I, Cetin G, Ozarslan I, Kuku I, Sincan G, Salim O, Namdaroglu S, Karakus A, Karakus V, Altuntas F, Sari I, Ozet G, Aydogdu I, Okan V, Kaya E, Yildirim R, Yildizhan E, Ozgur G, Ozcebe OI, Payzin B, Akpinar S, Demirkan F. Tekgündüz E, et al. Among authors: akpinar s. Transfus Apher Sci. 2018 Feb;57(1):27-30. doi: 10.1016/j.transci.2018.02.012. Epub 2018 Feb 20. Transfus Apher Sci. 2018. PMID: 29503132
The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL.
Akpinar S, Dogu MH, Celik S, Ekinci O, Hindilerden IY, Dal MS, Davulcu EA, Tekinalp A, Hindilerden F, Ozcan BG, Hacibekiroglu T, Erkurt MA, Bagci M, Namdaroglu S, Korkmaz G, Bilgir O, Cagliyan GA, Ozturk HBA, Serin I, Tiryaki TO, Ozatli D, Korkmaz S, Ulas T, Eser B, Turgut B, Altuntas F. Akpinar S, et al. Clin Lymphoma Myeloma Leuk. 2022 Mar;22(3):169-173. doi: 10.1016/j.clml.2021.09.010. Epub 2021 Sep 15. Clin Lymphoma Myeloma Leuk. 2022. PMID: 34629286
Prospective registry of adult patients receiving therapeutic plasma exchange with a presumptive diagnosis of thrombotic microangiopathy (TMA): The Turkish hematology research and education group (ThREG)-TMA02 study.
Akpınar S, Tekgunduz E, Erkurt MA, Esen R, Yılmaz M, Karakus V, Vural F, Gediz F, Aydogdu I, Kaynar L, Korkmaz S, Goker H, Kelkitli E, Ayyıldız O, Demirkan F. Akpınar S, et al. Transfus Apher Sci. 2021 Nov 16:103312. doi: 10.1016/j.transci.2021.103312. Online ahead of print. Transfus Apher Sci. 2021. PMID: 34799244
Prospective registry of adult patients receiving therapeutic plasma exchange with a presumptive diagnosis of thrombotic microangiopathy (TMA): The Turkish hematology research and education group (ThREG)-TMA02 study.
Akpinar S, Tekgunduz E, Esen R, Yilmaz M, Karakus V, Vural F, Gediz F, Aydogdu I, Kaynar L, Goker H, Kelkitli E, Ayyildiz O, Demirkan F. Akpinar S, et al. Transfus Apher Sci. 2022 Feb;61(1):103365. doi: 10.1016/j.transci.2022.103365. Epub 2022 Jan 24. Transfus Apher Sci. 2022. PMID: 35120823
Defibrotide combined with triple therapy including posttransplant cyclophosphamide, low dose rabbit anti-t-lymphocyte globulin and cyclosporine is effective in prevention of graft versus host disease after allogeneic peripheral blood stem cell transplantation for hematologic malignancies.
Akpinar S, Kayikci O, Tekgunduz E. Akpinar S, et al. Transfus Apher Sci. 2022 Feb;61(1):103367. doi: 10.1016/j.transci.2022.103367. Epub 2022 Jan 24. Transfus Apher Sci. 2022. PMID: 35120825 Review.
Real-Life Experience Regarding Clinical Characteristics and Treatment Outcome in Non-Cutaneous Peripheral T-Cell Lymphomas: A Multicenter Study of the Turkish Hematology Research and Education Group (ThREG).
Kayıkçı Ö, Mehtap Ö, Sarı İ, Demirkan F, Beyan C, Çetin G, Vural F, Yılmaz M, Öztürk E, Akpınar S, Eser B, Gündüz M, Büyükaşık Y, Payzın B, Yıldırım R, Doğu MH, Özkan A, Kelkitli E, Tekgündüz E. Kayıkçı Ö, et al. Among authors: akpinar s. Turk J Haematol. 2022 Aug 25;39(3):170-177. doi: 10.4274/tjh.galenos.2022.2022.0052. Epub 2022 Jun 9. Turk J Haematol. 2022. PMID: 35678126 Free PMC article.
203 results